17:11 EDT DiaMedica Therapeutics (DMAC) files $100M mixed securities shelf
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DMAC:
- DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
- DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
- DiaMedica Appoints New Chief Medical Officer
- DiaMedica Therapeutics files to sell 8.61M common shares for holders